
EU lists rare nerve disorder as side-effect of J&J Covid-19 vaccine
India Today
Following a review of 108 cases reported worldwide, Europe's medicines regulator announced on Thursday that a rare nerve-degeneration disorder, Guillain-Barré syndrome, had been added as a possible rare side effect of Johnson & Johnson's Covid-19 vaccine.
Europe's medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson's Covid-19 vaccine after it reviewed 108 cases reported worldwide. “After assessing the available data, PRAC considered that a causal relationship between Covid-19 vaccine Janssen and GBS is possible,” the European Medicines Agency said, referring to its safety committee, PRAC.More Related News

Egypt has emerged as a key back-channel mediator, establishing contact with Iran's IRGC and proposing a five-day pause in fighting to build momentum for a ceasefire, a move that appears to have nudged US President Donald Trump to drop his threat to strike Iran's power plants, The Wall Street Journal reported.












